Edward J. Gane

Dr. Gane is Professor of Medicine at the University of Auckland, New Zealand, Hepatologist and Deputy Director of the New Zealand Liver Unit at Auckland City Hospital.

Dr. Gane trained in hepatology at the Institute of Liver Studies, King’s College School of Medicine, London, where he completed his MD on the pathogenesis of hepatitis C-related liver injury. In 1998, Dr. Gane was appointed as Chief Physician for the first New Zealand Liver Unit at Auckland City Hospital, which provides a national transplant and HCC programme. Dr Gane helped set up the community-based national HBV Surveillance Programme, which is the largest in the world. He now chairs the Ministry of Health committee responsible for HCV elimination.

Dr. Gane is an investigator for many international clinical trials with particular interest in early phase development of new direct acting antiviral therapies against chronic hepatitis C, hepatitis B, NASH and HCC. He has published almost 350 papers in peer-reviewed journals including The Lancet and The New England Journal of Medicine.

In 2011, Dr. Gane was awarded Member of the Order of New Zealand for Services to Medicine and in 2017, was New Zealand Innovator of the Year for his work towards HCV elimination in New Zealand. In 2018, he was elected to the Royal Society of Medicine (New Zealand).